Mina Devine
Psychiatric/Mental Health · Cincinnati, OHNPI 1023539954
Payments from drug & device makers
Across 176 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sunovion Pharmaceuticals Inc.$369
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$285
- Alkermes, Inc.$285
- Otsuka America Pharmaceutical, Inc.$239
- Lundbeck LLC$230
- plus $382 from 7 others
What the payments were for
- Speaking & faculty fees$1,02528%
- Food & beverage$2,57369%
- Education$1233%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $1,931 |
| Sunovion Pharmaceuticals Inc. | 22 | $369 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $285 |
| Alkermes, Inc. | 7 | $285 |
| Otsuka America Pharmaceutical, Inc. | 17 | $239 |
| Lundbeck LLC | 18 | $230 |
| Johnson & Johnson | 10 | $141 |
| Teva Pharmaceuticals USA, Inc. | 7 | $114 |
| Indivior Inc. | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| Noven Therapeutics, LLC | 2 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$1,025
- ARISTADA$420
- CAPLYTA$112
- ARISTADA INITIO$105
How this compares
$3,721 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 16 | $3,783 |
| Quetiapine Fumarate | 27 | $322 |
| Buspirone Hcl | 16 | $292 |
| Hydroxyzine Pamoate | 16 | $279 |
| Fluoxetine Hcl | 22 | $162 |
| Divalproex Sodium | 15 | $132 |
| Mirtazapine | 16 | $113 |
| Benztropine Mesylate | 13 | $17 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Cincinnati
- Terri PopovitzCincinnati$161K
- Michelle McBrideCincinnati$29K
- Seth FramptonCincinnati$10K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.